Switch to:
More From Other Websites
Infinity Announces Presentations On Investigational Development Candidates, Duvelisib And IPI-549,... May 19 2016
Infinity Announces Presentations On Investigational Development Candidates, Duvelisib And IPI-549,... May 19 2016
ETF’s with exposure to Infinity Pharmaceuticals, Inc. : May 12, 2016 May 12 2016
Infinity Pharmaceuticals, Inc. :INFI-US: Earnings Analysis: Q1, 2016 By the Numbers May 11 2016
Disney Shutters Infinity Unit in Retreat From Video Games May 10 2016
INFINITY PHARMACEUTICALS, INC. Financials May 10 2016
Edited Transcript of INFI earnings conference call or presentation 4-May-16 8:30pm GMT May 05 2016
Infinity reports 1Q loss May 04 2016
Infinity reports 1Q loss May 04 2016
Infinity Provides Company Update And Reports First Quarter 2016 Financial Results May 04 2016
Infinity Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today May 04 2016
INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... May 04 2016
Infinity Provides Company Update And Reports First Quarter 2016 Financial Results May 04 2016
INFINITY PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report May 04 2016
Q1 2016 Infinity Pharmaceuticals Inc Earnings Release - After Market Close May 04 2016
Infinity to Participate in Three May Investor Conferences Apr 27 2016
Infinity to Participate in Three May Investor Conferences Apr 27 2016
Infinity Announces the Date of its First Quarter 2016 Financial Results Conference Call and Webcast Apr 20 2016
Infinity Announces the Date of its First Quarter 2016 Financial Results Conference Call and Webcast Apr 20 2016
IPI-549 Alters the Immune-Suppressive Microenvironment and Enhances the Activity of Checkpoint... Apr 18 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK